AGL 37.50 Decreased By ▼ -0.08 (-0.21%)
AIRLINK 222.89 Increased By ▲ 0.46 (0.21%)
BOP 10.82 Decreased By ▼ -0.14 (-1.28%)
CNERGY 7.56 Decreased By ▼ -0.10 (-1.31%)
DCL 9.42 Decreased By ▼ -0.21 (-2.18%)
DFML 40.96 Decreased By ▼ -0.74 (-1.77%)
DGKC 106.76 Decreased By ▼ -3.99 (-3.6%)
FCCL 37.07 Decreased By ▼ -0.99 (-2.6%)
FFL 19.24 Increased By ▲ 0.95 (5.19%)
HASCOL 13.18 Decreased By ▼ -0.19 (-1.42%)
HUBC 132.64 Decreased By ▼ -2.32 (-1.72%)
HUMNL 14.73 Decreased By ▼ -0.86 (-5.52%)
KEL 5.40 Decreased By ▼ -0.16 (-2.88%)
KOSM 7.48 Increased By ▲ 0.07 (0.94%)
MLCF 48.18 Decreased By ▼ -2.15 (-4.27%)
NBP 66.29 Decreased By ▼ -0.18 (-0.27%)
OGDC 223.26 Decreased By ▼ -5.35 (-2.34%)
PAEL 43.50 Increased By ▲ 0.13 (0.3%)
PIBTL 9.07 Decreased By ▼ -0.23 (-2.47%)
PPL 198.24 Decreased By ▼ -4.89 (-2.41%)
PRL 42.24 Decreased By ▼ -0.62 (-1.45%)
PTC 27.39 Increased By ▲ 0.06 (0.22%)
SEARL 110.08 Increased By ▲ 3.06 (2.86%)
TELE 10.52 Increased By ▲ 0.74 (7.57%)
TOMCL 36.62 Decreased By ▼ -0.01 (-0.03%)
TPLP 14.95 Decreased By ▼ -0.28 (-1.84%)
TREET 26.53 Decreased By ▼ -0.26 (-0.97%)
TRG 68.85 Decreased By ▼ -1.30 (-1.85%)
UNITY 34.19 No Change ▼ 0.00 (0%)
WTL 1.79 Increased By ▲ 0.03 (1.7%)
BR100 12,363 Decreased By -32.9 (-0.27%)
BR30 38,218 Decreased By -629.2 (-1.62%)
KSE100 117,120 Increased By 111.6 (0.1%)
KSE30 36,937 Increased By 72.2 (0.2%)

LONDON: London's mid-cap stocks climbed on Monday on bets that a Brexit trade deal between Britain and the European Union was still possible, while drugmaker AstraZeneca slid on a $39 billion buyout of US-based Alexion Pharmaceuticals. The domestically focussed FTSE 250, considered a barometer for Brexit sentiment, closed about 0.7% higher although it was off its session highs with financial and consumer discretionary stocks providing the biggest boost.

A strong pound took the shine off of the exporter-heavy FTSE 100, down 0.2% as London and Brussels agreed to "go the extra mile" in coming days to try to reach an elusive trade agreement.

In company news, AstraZeneca shares sank 5.7% as investors moved to price in the drugmaker's $39 billion deal for biotech firm Alexion, one of this year's biggest mergers globally.

Codemasters soared 22.4% after Electronic Arts said it would buy the video game developer in a deal worth $1.2 billion, trumping an earlier agreement between the British company and rival Take-Two Interactive Software.

"With the vaccine roll-out set to produce a marked pick-up in growth from the second quarter onwards, markets should remain well supported despite any worries over the deteriorating near term outlook," said Rupert Thompson, chief investment officer at Kingswood.

London's stock indexes have tracked a rally in global equity markets as signs of working Covid-19 vaccines raised hopes of a faster economic rebound next year. But gains have been capped by fears around the near-term economic damage from business curbs and mass layoffs.

Comments

Comments are closed.